InvestorsHub Logo
Followers 30
Posts 2559
Boards Moderated 0
Alias Born 04/01/2009

Re: Ultimate01 post# 327

Saturday, 01/21/2017 4:34:31 PM

Saturday, January 21, 2017 4:34:31 PM

Post# of 879
Thought I would mention an item which would affect the SP of BIVI.

In an attack "article" this week on Seeking Alpha against Cellceutix, BIVI was mentioned as a possible future target:

"Method 2: Wait for the next Ehrlich and Menon "special" to incubate
Many market participants may be unaware that yet another Ehrlich and Menon stock trades on the pink sheets: Nanoantibiotics (OTCPK:BIVI). According to Reuters, the company is run by Elliot Ehrlich and Rajah Menon, who we believe are likely related to Leo Ehrlich and Krishna Menon of Cellceutix. Although clearly shorting a $0.30 stock is problematic, we recommend investors keep a close eye on BIVI and revisit it in the event the shares ever trade to a higher price level. Mako Research certainly plans to do so.
Disclosure: I am/we are short CTIX."

While Mako's articles are entirely crap, there are people who reflexively sell ANY stock which is under attack and figure out potential validity later.

Just thought we holders should not be surprised or sell as a reflex if BIVI is attacked.

All I say is IMHO and not to be construed as investment advice. I know nothing, as informed frequently by my wife.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BIVI News